psalexa
P&S Market Research - A market research firm

Encephalopathy Therapeutics Pipeline Analysis

Encephalopathy Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11154
Available Format:

Encephalopathy is a disease that affects the structure and functioning of the brain, which can be permanent or temporary. The different types of encephalopathy include chronic traumatic encephalopathy, glycine encephalopathy, Hashimoto’s encephalopathy, hepatic encephalopathy, hypertensive encephalopathy, hypoxic ischemic encephalopathy, toxic-metabolic encephalopathy, infectious encephalopathies, uremic encephalopathy and Wernicke encephalopathy. Some of the symptoms associated with the disease inclcude mental changes, muscle weakness, trembling, involuntary twitching, difficulty speaking or swallowing and seizures. The disease can be prevented by avoiding excess alcohol, eating a healthy diet and reducing exposure to toxic substances such as drugs. Rebiotix Inc. is in the process of developing RBX2660 for the treatment of hepatic encephalopathy as an enema formulation. Some of the other companies having a pipeline of encephalopathy include Greenwich Biosciences, Inc., and GW Pharmaceuticals, plc.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities, including information about clinical results, designations, collaborations, licencing, grants, technology and others.

Place An Order

Single User License
question-mark

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License
question-mark

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License
question-mark

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry